DE60024100D1 - Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen - Google Patents

Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen

Info

Publication number
DE60024100D1
DE60024100D1 DE60024100T DE60024100T DE60024100D1 DE 60024100 D1 DE60024100 D1 DE 60024100D1 DE 60024100 T DE60024100 T DE 60024100T DE 60024100 T DE60024100 T DE 60024100T DE 60024100 D1 DE60024100 D1 DE 60024100D1
Authority
DE
Germany
Prior art keywords
virus
proteins
syndrome
white patches
uses derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60024100T
Other languages
English (en)
Inventor
Hulten Cornelia Van
Maria Vlak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE60024100D1 publication Critical patent/DE60024100D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60024100T 1999-08-03 2000-07-26 Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen Expired - Lifetime DE60024100D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202545 1999-08-03
EP00200248 2000-01-24
PCT/EP2000/007290 WO2001009340A1 (en) 1999-08-03 2000-07-26 Proteins derived from white spot syndrome virus and uses thereof

Publications (1)

Publication Number Publication Date
DE60024100D1 true DE60024100D1 (de) 2005-12-22

Family

ID=26071765

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60024100T Expired - Lifetime DE60024100D1 (de) 1999-08-03 2000-07-26 Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen

Country Status (14)

Country Link
US (2) US7749506B2 (de)
EP (1) EP1206550B1 (de)
JP (1) JP4786093B2 (de)
CN (2) CN1170934C (de)
AT (1) ATE310089T1 (de)
AU (1) AU771049B2 (de)
BR (1) BR0012919A (de)
CA (1) CA2380833C (de)
DE (1) DE60024100D1 (de)
EC (1) ECSP093601A (de)
MX (1) MXPA02001223A (de)
MY (1) MY131143A (de)
TW (1) TWI266802B (de)
WO (1) WO2001009340A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3780256B2 (ja) * 2000-09-15 2006-05-31 アクゾ・ノベル・エヌ・ベー 小エビ白斑病症候群（ＷｈｉｔｅＳｐｏｔＳｙｎｄｒｏｍｅ）ウイルスの抗原性蛋白質及びその使用
WO2003000900A1 (en) * 2001-06-22 2003-01-03 Akzo Nobel N.V. White spot syndrome virus vaccine
US7550647B2 (en) 2001-09-14 2009-06-23 Advanced Bionutrition Transfected shrimp as production systems for therapeutic proteins
AU2003270652A1 (en) * 2002-09-16 2004-04-30 Advanced Bionutrition Corporation Protein and peptide expression for passive immunity
KR100489617B1 (ko) * 2002-09-24 2005-05-17 주식회사 단바이오텍 흰반점바이러스 감염의 예방 및 치료를 위한 수용성 항체단백질 및 이를 포함한 알, 및 이들의 제조방법
BRPI0412282A (pt) * 2003-07-02 2006-09-19 Musc Found For Res Dev imunidade especìfica e não-especìfica induzida de dsrna em crustáceos e outros invertebrados, e veìculos de bioliberação para uso nestes
AU2004271211A1 (en) * 2003-09-09 2005-03-17 Aqua Bounty Technologies, Inc. Compositions and methods for inhibiting White Spot Syndrome Virus (WSSV) infection
WO2006005222A1 (fr) * 2004-07-09 2006-01-19 Green Life Laboratory Limited Proteine p40 obtenue par genie genetique et utilisation
JP2008169131A (ja) * 2007-01-10 2008-07-24 Univ Of Miyazaki 甲殻類急性ウイルス血症に対するｄｎａワクチン
JP5649188B2 (ja) * 2009-07-09 2015-01-07 国立大学法人 宮崎大学 クルマエビ科生物の急性ウイルス血症に対するワクチン
CN101691403B (zh) * 2009-08-03 2011-11-09 中国海洋大学 抗对虾白斑症病毒囊膜蛋白vp28独特型单克隆抗体及其制备方法
EP2482825B1 (de) 2009-10-02 2016-11-23 The Trustees of Columbia University in the City of New York Diagnostische fisch-reoviren-zusammensetzungen
US10004797B2 (en) 2010-10-27 2018-06-26 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
WO2012058073A2 (en) 2010-10-27 2012-05-03 Harrisvaccines, Inc. Methods and compositions to protect aquatic invertebrates from disease
US8822427B2 (en) 2010-10-27 2014-09-02 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
MY153741A (en) 2010-11-10 2015-03-13 Univ Malaya A method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof
MY161995A (en) * 2010-11-10 2017-05-31 Univ Malaya Vaccine against white spot syndrome virus
CN109517037B (zh) * 2018-10-31 2022-02-08 青岛科技大学 具有白斑综合征病毒抑制作用的多肽及其应用
CN109821013B (zh) * 2018-12-17 2022-06-14 潍坊麦吉迪生物科技有限公司 抗对虾白斑病疫苗及其制备方法
JPWO2022158453A1 (de) * 2021-01-20 2022-07-28
CN114600811A (zh) * 2022-04-21 2022-06-10 中国水产科学研究院黄海水产研究所 一种中国对虾核心育种群wssv的净化方法
CN117701777A (zh) * 2024-01-22 2024-03-15 烟台海关技术中心 WSSV检测引物、crRNA、CRISPR组合物、试剂盒及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU674684B2 (en) * 1992-07-20 1997-01-09 Sterno Group LLC, The Gelled organic liquids
US5824535A (en) * 1996-01-17 1998-10-20 Kou; Guang-Hsiung Identification, purification and detection of WSBV (Baculovirus associated with white spot syndrome)
JPH09201196A (ja) * 1996-01-25 1997-08-05 Koyu Kaku 白斑症候群関連バキュロウイルスの同定、精製および検出

Also Published As

Publication number Publication date
JP2003506338A (ja) 2003-02-18
MXPA02001223A (es) 2002-07-30
CA2380833C (en) 2011-03-15
US7749506B2 (en) 2010-07-06
AU6832000A (en) 2001-02-19
BR0012919A (pt) 2002-04-23
ATE310089T1 (de) 2005-12-15
JP4786093B2 (ja) 2011-10-05
CN1170934C (zh) 2004-10-13
ECSP093601A (es) 2009-08-28
CN1626241A (zh) 2005-06-15
US20100324125A1 (en) 2010-12-23
CN1367834A (zh) 2002-09-04
US8114977B2 (en) 2012-02-14
MY131143A (en) 2007-07-31
WO2001009340A1 (en) 2001-02-08
US20090068212A1 (en) 2009-03-12
TWI266802B (en) 2006-11-21
EP1206550B1 (de) 2005-11-16
AU771049B2 (en) 2004-03-11
CA2380833A1 (en) 2001-02-08
EP1206550A1 (de) 2002-05-22

Similar Documents

Publication Publication Date Title
DE60024100D1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
ATE427116T1 (de) Behandlung von bakteriellen infektionen
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
MXPA03000626A (es) Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de la hepatitis c.
AU2002305450A1 (en) Proteomimetic compounds and methods
BRPI0514176A (pt) inibidores de replicação de hcv
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
PT1411908E (pt) Tratamento de infeccoes da unha com no
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
ATE248835T1 (de) Prodrugs von impdh-inhibierenden carbamaten
BR0009721A (pt) Inibidores de tirosina quinase de proteìna cìclica
HUP0002224A1 (hu) Virusellenes hatású benzimidazol-származékok
BR0210335A (pt) Copolìmero de blocos, e, composição
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE60136381D1 (de) Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
TR200102024T2 (tr) Yeni tedavi.
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
EA200500533A1 (ru) Пептидные производные - ингибиторы слияния при вич-инфекции
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
ATE521640T1 (de) Anti-tsg101-antikörper und ihre verwendungen bei der behandlung von virusinfektionen
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen

Legal Events

Date Code Title Description
8332 No legal effect for de